Results 141 to 150 of about 27,731 (238)

Menopausal hormone therapy after ovarian cancer: A 10‐year survival analysis in premenopausal women

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1468-1479, August 2026.
Among premenopausal women surgically treated for ovarian cancer, no difference in 10‐year overall survival was observed between postoperative MHT users and non‐users. Young ovarian cancer survivors should be recommended MHT after surgically induced menopause.
Åsa Ehlin von Kartaschew   +4 more
wiley   +1 more source

MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy

open access: yesCancer Science, Volume 117, Issue 8, Page 2085-2097, August 2026.
MTAP deletion creates a therapeutically actionable metabolic vulnerability through MTA accumulation and PRMT5 dependency. This review summarizes the biochemical basis of MTAP‐directed synthetic lethality, emerging PRMT5/MAT2A inhibitors, clinicogenomic features of MTAP‐deleted tumors, and future strategies for precision oncology.
Hiroaki Ikushima, Hidenori Kage
wiley   +1 more source

Sertoli Cell-Derived Extracellular Vesicles Orchestrate Cadmium-Induced Testicular Inflammation and Fibrosis. [PDF]

open access: yesAdv Sci (Weinh)
Ma J   +17 more
europepmc   +1 more source

Naproxen and Ibuprofen Exposure Alter the Blood-Testis Barrier in a Novel In Vitro Model. [PDF]

open access: yesInt J Mol Sci
Crow KMS   +15 more
europepmc   +1 more source

NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post‐translational modifications

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Nucleoporins (NUPs) constitute the nuclear pore complex (NPC) and are essentially involved in nuclear transport, chromatin organization, and context‐dependent gene regulation. However, the role of NUPs in neuroendocrine (tumor)biology and related diagnostic potential is poorly defined.
Sven Mattern   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy